Analytical Data
-
基因名
LY6G6D
- Application
-
别名
LY66D_HUMAN; Ly6g6d; Lymphocyte antigen 6 complex locus proteof G6d; Megakaryocyte-enhanced gene transcript 1 protein; Proteof Ly6-D
-
种属
Human
-
表达系统
HEK293
-
标签
N-Avi;N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O95868
-
表达区间
N20-S104
-
分子量
15-18 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LY6G6D, a member of the Ly-6 (Ly-6E, Ly-6C, etc.) superfamily, is a glycosylphosphatidylinositol (GPI)-anchored protein predominantly expressed on immune cells. Recent studies have highlighted its potential role in modulating immune responses, making it a target of interest for immunological research. The protein is believed to interact with various receptors and signaling pathways, influencing key processes such as T cell activation and differentiation. Understanding the functional mechanisms of LY6G6D could unveil new insights into its contributions to immune regulation and disease pathogenesis, including autoimmunity and cancer. Consequently, recombinant LY6G6D protein is being developed for a range of experimental applications, such as functional assays and structural studies, to elucidate its biological roles. This research aims to clarify how LY6G6D influences immune cell behavior and its potential therapeutic implications, thereby contributing to the development of innovative immunotherapies and treatments for immune-related disorders.
